RECOMBINANT DNA PRODUCTS FOR USE IN THE TREATMENT OF GENETIC DISORDERS NAMELY NUCLEIC ACID VACCINES, GENE THERAPY VECTORS, FUSION PROTEIN VACCINES, CANCER VACCINES, AND INFECTIOUS DISEASE VACCINES EXCLUDING PHARMACEUTICALS USED IN THE TREATMENT OR PREVENTION OF HEPATITIS A, B, C, D, E, or F

'acid':14 'b':39 'c':40 'cancer':22 'd':41 'diseas':26 'disord':11 'dna':2 'e':42 'exclud':28 'f':44 'fusion':19 'gene':16 'genet':10 'hepat':37 'infecti':25 'name':12 'nucleic':13 'pharmaceut':29 'prevent':35 'product':3 'protein':20 'recombin':1 'therapi':17 'treatment':8,33 'use':5,30 'vaccin':15,21,23,27 'vector':18

CONSULTATION IN THE FIELDS OF REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE, REAGENTS FOR VACCINE PRODUCTIONS, CELL CULTURE, AND GENE TRANSFER OR RECOMBINANT DNA PRODUCTS INCLUDING PROTEINS FOR USE IN THE TREATMENT OF DISEASES AND DISORDERS, NAMELY NUCLEIC ACID VACCINES, GENE THERAPY VECTORS, FUSION PROTEIN VACCINES, CANCER VACCINES, CELL-BASED VACCINES AND INFECTIOUS DISEASE VACCINES

'acid':39 'base':51 'cancer':47 'cell':17,50 'cell-bas':49 'consult':1 'cultur':18 'diseas':34,55 'disord':36 'dna':24 'field':4 'fusion':44 'gene':20,41 'includ':26 'infecti':54 'medic':10 'name':37 'nucleic':38 'product':16,25 'protein':27,45 'reagent':6,13 'recombin':23 'research':11 'scientif':8 'therapi':42 'transfer':21 'treatment':32 'use':12,29 'vaccin':15,40,46,48,52,56 'vector':43

REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE, REAGENTS FOR VACCINE PRODUCTION, CELL CULTURE AND GENE TRANSFER

'cell':12 'cultur':13 'gene':15 'medic':5 'product':11 'reagent':1,8 'research':6 'scientif':3 'transfer':16 'use':7 'vaccin':10

GENITRIX

Owners

Goods & Services